Fentanyl Rehab With Long-Term MAT

Fentanyl rehab at GEVS Recovery starts here. The 30-day floor is rarely enough for fentanyl. Most clients land in the 60 to 90 day window because fentanyl tolerance pharmacology, the relapse-overdose mortality risk, and the MAT stabilization timeline all push longer. The first 90 days post-detox carry the highest relapse window, and an unsupervised relapse with fentanyl-tolerant receptors is uniquely dangerous. Residential gives the client structured time inside that window.

Long-term MAT for fentanyl runs months to years rather than 30 days. The four standard options are Sublocade as monthly injection, oral Suboxone as daily film, methadone where it fits the case, and Vivitrol (naltrexone) for clients ready and stable. Long-term matters because fentanyl tolerance and relapse-overdose mortality risk persist long after acute withdrawal. Buprenorphine maintenance reduces mortality during and after residential.

Most street fentanyl now contains xylazine, often sold as tranq. Naloxone reverses fentanyl but does not reverse xylazine — that is the most important safety fact for any household with naloxone in the cabinet. Xylazine-aware fentanyl rehab integrates the opioid component with alpha-2 monitoring and wound care if needed. We name it explicitly because the wave of xylazine-laced supply is the reason naloxone-only thinking fails on the street.

Most major insurers cover residential fentanyl addiction treatment plus ongoing MAT under SUD parity. Blue Cross Blue Shield, Aetna, Cigna, Carelon Behavioral Health, Optum Behavioral Health, Magellan Health plans we work with regularly. Coverage typically includes medically necessary residential care with length-of-stay reviewed at intervals, plus continuing MAT post-discharge.